Source:http://linkedlifedata.com/resource/pubmed/id/19741597
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-10-16
|
pubmed:abstractText |
The chemokine CXCL13 is overexpressed in the intestine during inflammation. To mimic this condition, we created transgenic mice-expressing CXCL13 in intestinal epithelial cells. CXCL13 expression promoted a marked increase in the number of B cells in the lamina propria and an increase in the size and number of lymphoid follicles in the small intestine. Surprisingly, these changes were associated with a marked increase in the numbers of RORgammat(+)NKp46(-)CD3(-)CD4(+) and RORgammat(+)NKp46(+) cells. The RORgammat(+)NKp46(-)CD3(-)CD4(+) cells expressed CXCR5, the receptor for CXCL13, and other markers of lymphoid tissue-inducer cells, such as LTalpha, LTbeta, and TNF-related activation-induced cytokine (TRANCE). RORgammat(+)NKp46(-)CD3(-)CD4(+) gut LTi cells produced IL-22, a cytokine implicated in epithelial repair; and expressed the IL-23 receptor, a key regulator of IL-22 production. These results suggest that overexpression of CXCL13 in the intestine during inflammatory conditions favors mobilization of B cells and of LTi and NK cells with immunomodulatory and reparative functions.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1935-3456
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
486-94
|
pubmed:meshHeading |
pubmed-meshheading:19741597-Animals,
pubmed-meshheading:19741597-B-Lymphocytes,
pubmed-meshheading:19741597-Chemokine CXCL13,
pubmed-meshheading:19741597-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19741597-Flow Cytometry,
pubmed-meshheading:19741597-Immunity, Mucosal,
pubmed-meshheading:19741597-Immunohistochemistry,
pubmed-meshheading:19741597-Inflammation,
pubmed-meshheading:19741597-Interleukins,
pubmed-meshheading:19741597-Intestinal Mucosa,
pubmed-meshheading:19741597-Killer Cells, Natural,
pubmed-meshheading:19741597-Lymphoid Tissue,
pubmed-meshheading:19741597-Mice,
pubmed-meshheading:19741597-Mice, Transgenic,
pubmed-meshheading:19741597-Polymerase Chain Reaction,
pubmed-meshheading:19741597-Stem Cells
|
pubmed:year |
2009
|
pubmed:articleTitle |
CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles.
|
pubmed:affiliation |
Immunology Institute, Mount Sinai School of Medicine, New York, New York, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|